Risk factors
Allarity Therapeutics (ALLR) risk factors
Item 1A of every Allarity Therapeutics, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
90 risks, no changes since the prior year. This company faces no prior year comparisons for risk factor changes in this filing period.
Filed Mar 30, 2026 - FY2024 10-K risk factors
90 risks. Clinical stage biopharmaceutical company focused on developing stenoparib for ovarian cancer using its DRP platform.
Filed Mar 31, 2025